Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_276164141bff1b671b52ceb89dd1b779 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-01011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1205 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 |
filingDate |
2007-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2010-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0dc9ebaefa95cec5f8302a6359776f01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c008d21bc18ce6fdfc22dfc61ec05e3c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5ba34212da5625a3694ab352192a96a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ea4977bf06c9d44ef5599554bf85543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17e1be49f7c70e4291a31637fdd9c6ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f809bf92fc8f75eef0726c31d0f6efdd |
publicationDate |
2010-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7807404-B2 |
titleOfInvention |
Mutated truncated mt-pfkA gene for the synthesis of active shorter fragment of 6-phosphofructo-1-kinase |
abstract |
The invention deals with mutated truncated mt-pfkA gene encoding shorter fragment of 6-phosphofructo-1-kinase (PFK1), with no need for phosphorylation of the protein molecule for activation, that is not significantly inhibited by citric acid and/or its salts and ATP molecules. Active 49-52 kDa fragment encoded by mt-pfkA gene, retains positive regulatory properties of the native protein and is activated in the presence of specific activators, while citric acid and ATP, important metabolites that function as feed back inhibitors in higher organisms do not reduce its activity. The invention deals with the use of modified shorter fragment in biotechnological processes for fabricating primary and secondary metabolites. |
priorityDate |
2006-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |